We are live on
!
Find out more
PAS
Professional Advisory Services Portfolio holdings
AUM
$836M
1-Year Est. Return
25.79%
This Fund
S&P 500
This Quarter
Est. Return
+3.61%
1 Year Est. Return
+25.79%
3 Year Est. Return
+61.78%
5 Year Est. Return
+59.24%
10 Year Est. Return
+244.98%
AUM
$659M
AUM Growth
+$17M
(+2.7%)
Cap. Flow
-$4.44M
Cap. Flow
% of AUM
-0.67%
Top 10 Holdings %
Top 10 Hldgs %
37.73%
Holding
78
New
2
Increased
19
Reduced
25
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$19M |
| 2 |
Charles River Laboratories
CRL
|
+$11.8M |
| 3 |
CDW
CDW
|
+$3.73M |
| 4 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$3.69M |
| 5 |
Zebra Technologies
ZBRA
|
+$3.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$23.5M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$14.8M |
| 3 |
Microsoft
MSFT
|
+$4.69M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.56M |
| 5 |
PepsiCo
PEP
|
+$2.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.48% |
| 2 | Financials | 15.98% |
| 3 | Industrials | 15.72% |
| 4 | Healthcare | 15.22% |
| 5 | Consumer Discretionary | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Microsoft
MSFT
$2.97T
| $28M | 4.24% |
82,079
-14,959
| -15% | -$4.69M |
|
|
2
CDW
CDW
$16.5B
| $26.8M | 4.07% |
146,209
+21,353
| +17% | +$3.73M |
|
|
FISV
3
Fiserv Inc
FISV
$27.2B
| $26.6M | 4.04% |
210,771
-7,714
| -4% | -$908K |
|
4
Berkshire Hathaway Class B
BRK.B
$1.06T
| $26.2M | 3.98% |
76,858
-2,876
| -4% | -$939K |
|
5
United Parcel Service
UPS
$98.5B
| $25.6M | 3.89% |
142,886
+8,955
| +7% | +$1.59M |
|
|
6
Alphabet (Google) Class C
GOOG
$4.26T
| $24.8M | 3.76% |
204,994
-30,728
| -13% | -$3.56M |
|
7
Elevance Health
ELV
$84.5B
| $24.1M | 3.66% |
54,187
+3,016
| +6% | +$1.39M |
|
8
Analog Devices
ADI
$186B
| $22.6M | 3.43% |
115,851
+10,087
| +10% | +$1.87M |
|
9
Booking.com
BKNG
$138B
| $22.1M | 3.35% |
204,175
+6,900
| +3% | +$729K |
|
|
10
Zebra Technologies
ZBRA
$12.4B
| $21.8M | 3.31% |
73,793
+12,576
| +21% | +$3.53M |
|
|
11
PepsiCo
PEP
$184B
| $21.5M | 3.26% |
115,851
-13,934
| -11% | -$2.6M |
|
12
Johnson & Johnson
JNJ
$602B
| $20.7M | 3.15% |
125,307
+4,898
| +4% | +$791K |
|
13
Arthur J. Gallagher & Co
AJG
$63.8B
| $20.3M | 3.08% |
92,343
-4,277
| -4% | -$890K |
|
14
Stryker
SYK
$121B
| $20.2M | 3.06% |
66,096
-3,153
| -5% | -$911K |
|
15
TJX Companies
TJX
$170B
| $19.6M | 2.98% |
231,119
-234
| -0.1% | -$18.5K |
|
16
Fortune Brands Innovations
FBIN
$5.97B
| $19.4M | 2.95% |
270,211
+4,114
| +2% | +$262K |
|
17
Carrier Global
CARR
$56.1B
| $19.2M | 2.91% |
385,400
+14,091
| +4% | +$620K |
|
|
18
iShares MSCI Emerging Markets ex China ETF
EMXC
$24.1B
| $19.1M | 2.9% |
367,411
+72,908
| +25% | +$3.69M |
|
19
General Dynamics
GD
$100B
| $19M | 2.89% |
88,493
+14,038
| +19% | +$3.03M |
|
20
MSC Industrial Direct
MSM
$6.99B
| $19M | 2.89% |
199,493
-23,061
| -10% | -$2.11M |
|
21
Accenture
ACN
$86.8B
| $18.9M | 2.87% |
61,166
-6,705
| -10% | -$1.95M |
|
|
22
Thermo Fisher Scientific
TMO
$191B
| $18.9M | 2.86% |
36,133
+35,123
| +3,478% | +$19M |
|
23
Dollar General
DG
$27.3B
| $18.8M | 2.85% |
110,728
+10,789
| +11% | +$2.13M |
|
24
iShares Core MSCI EAFE ETF
IEFA
$187B
| $18.5M | 2.81% |
274,680
+50,426
| +22% | +$3.42M |
|
25
AT&T
T
$153B
| $17.6M | 2.67% |
1,104,422
+62,352
| +6% | +$1.06M |
|
Similar funds
FPGK
DLP
MCM
MAP
ES
CAM
SAIG
FM
Professional Advisory Services's Q2 2023 Portfolio in Review
As of Q2 2023, Professional Advisory Services held 78 positions worth $659M, up 2.7% from $642M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Professional Advisory Services's Q2 2023 filing shows 2 new, 19 increased, 25 reduced and 6 closed positions. Its largest new stake was Charles River Laboratories: 59,545 shares worth $12.5M. The largest sale was Medtronic, an estimated $23.5M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Financials and Industrials.
- Professional Advisory Services's largest Q2 2023 buy was Charles River Laboratories: 59,545 shares worth $12.5M.
- Professional Advisory Services added most to Thermo Fisher Scientific in Q2 2023, an estimated $19M increase.
- Professional Advisory Services's biggest Q2 2023 reduction was Medtronic, cutting an estimated $23.5M.
- Professional Advisory Services fully exited iShares Core MSCI Emerging Markets ETF in Q2 2023, selling an estimated $14.8M.
- Professional Advisory Services's ten largest holdings make up 38% of its $659M portfolio in Q2 2023.
- Professional Advisory Services opened 2 new positions and closed 6 in Q2 2023.
- Professional Advisory Services's portfolio value rose 2.7% quarter-over-quarter to $659M.
Based on Professional Advisory Services's 13F filing for Q2 2023, filed 10 Jul 2023.